リンソーム鉄の活性化により,がんにおけるフェロプトーシスが発生する
Tatiana Cañeque1, Leeroy Baron1, Sebastian Müller1
1Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Nature
|May 7, 2025
まとめ
研究者達は リゾソームに鉄を標的として 細胞死の一種であるフェロプトーシスを誘発することを発見しました この発見は 薬剤耐性持続細胞や転移を含む癌の治療戦略を 新たに提供しています
科学分野:
- 生物化学
- 細胞生物学
- ガン治療薬
背景:
- 鉄は細胞膜における脂質酸化を触媒化し,フェロプトーシスを引き起こします.
- 鉄による脂質酸化の細胞位置を理解することは,フェロプトーシスを調節する薬の開発の鍵です.
- リソソームはフェロプトーシスに関与しているが,鉄媒介による脂質酸化におけるそれらの特定の役割については,さらなる定義が必要である.
研究 の 目的:
- フェロプトーシスにおけるライソソームの役割を調査する.
- 治療上の利益のためにリソソムの鉄活性を調節できる小分子を特定する.
- 特に薬剤耐性および転移性細胞の癌治療におけるリゾソーマの鉄を標的とする可能性を調査する.
主な方法:
- フェロプトーシスを研究するために遺伝的および小分子アプローチを使用した.
- フェロプトーシス阻害剤リプロキシスタチン-1 とインダクターRSL3 が細胞の鉄と脂質酸化に及ぼす影響を研究した.
- フェントマイシン"と呼ばれる 線維鉄の新型小分子活性化剤を設計・合成した.
- 様々ながん細胞系 (肉腫,管腺がん) と乳がん転移のマウスモデルにおけるフェントマイシン-1の有効性を評価した.
主要な成果:
- フェロプトーシス阻害剤リプロキシスタチン-1は,リソソーム内の鉄を不活性化することによって機能する.
- フェロプトーシス誘導体RSL3は,リソソームから発生する膜脂質酸化を誘発する.
- フェントマイシン-1は酸化性フォスホリピドの分解とフェロプトーシスを効果的に誘発し,特にCD44濃度の高い肉腫と臓がん細胞に作用する.
- サブレタルフェントミシン-1で治療された肉腫細胞は,メゼンキーママーカーをダウンレギュレーションし,膜損傷応答を活性化することで抵抗性を発達させた.
- フェントマイシン-1は,耐性がん細胞をインビトロで除去し,臨床前の転移モデルで腫瘍の増殖を抑制する効果を示した.
結論:
- リソソムの鉄はフェロプトーシスを誘発し,治療上の利点を与えるための薬剤対象である.
- ライソソームの鉄反応性を制御することは がん治療の有望な戦略です
- 薬剤耐性持続細胞の 特定の細胞状態をターゲットにすることは 価値ある治療法です
関連する概念動画
01:16Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:28The Early Endosome: Endocytosis of Transferrin
3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:30Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K